Direxion Daily S&P Biotech Bear 3X ETF ETF Prediction and Forecast [LABD]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 12 Nov 2025, 04:48 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Direxion Daily S&P Biotech Bear 3X ETF ETF Prediction and Forecast [LABD]](https://i.ytimg.com/vi/8gvGrI2GSe0/hqdefault.jpg)
AI-generated source summary
The Direxion Daily S&P Biotech Bear 3X ETF (LABD) exhibits a bearish trend, with multiple indicators suggesting further downside. Technical analysis points to key resistance levels at $30.20 and $33.85, while a breakdown above these levels could signal a shift. The ETF has experienced significant volatility, with a negative score and a sell candidate ranking. The overall outlook for LABD remains bearish, with potential for further decline in the short to medium term.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.